Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
D000328:Adult; D000368:Aged; D002389:Catatonia / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010868:Pimozide / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy*; D012562:Schizophrenia, Disorganized / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D010919:Placebos; D014149:Tranquilizing Agents; D010868:Pimozide